iXensor, the pioneer of mobile health, infuses its corporate DNA of digital savviness into its upcoming product launch in January 2021. The PixoTest® COVID-19 Antigen Test, together with the PixoTest® POCT Analyzer, can yield positive results objectively in as short as 5 minutes through computer-aided analysis, minimizing the chances of misinterpretation by…
PixoTest POCT System and PixoTech technology covered in Health & Care Management
iXensor attended Medica 2020 in October and presented the PixoTech technology as well as its new application of smart COVID-19 management. “Health & Care Management” from Germany reported it as “Pioneering medical technology from Taiwan.” Read the full article here: https://www.hcm-magazin.de/zukunftsweisende-medizintechnik-aus-taiwan/150/25761/408612
iXensor announces its residency at Johnson Innovation’s JLABS
iXensor announced today that, effective December 1st, it has become a resident of Johnson & Johnson Innovation – JLABS @ Shanghai. This is an important step toward further accelerating its PixoTech platform development and smartphone-based testing applications for new disease areas, leveraging JLABS’ global network and resources. Johnson Innovation…
iXensor ventured into a radically decentralized telemedicine journey for at-home rapid flu testing with Startup Creasphere
TAIPEI, TAIWAN / SINGAPORE – November 25th, 2020 – iXensor Co., Ltd. (6734.TWO) Backed by two pharmaceutical giants Roche, Sanofi and organized by Plug and Play, the Startup Creasphere Program selected iXensor to join its three-month digital health accelerator program, which aimed for transforming healthcare together. In this first…
iXensor expedites the remote co-development of Deficiency of Adenosine Deaminase 2 rapid test at DADA2 conference
At the 3rd International Conference on Deficiency of Adenosine Deaminase 2 (DADA2), the CEO of iXensor, Dr. Carson Chen, speaks about XLab and its applications in realizing remote collaboration of developing accessible and affordable DADA2 diagnostic test with test strip developers across the globe. Dr. Carson Chen encountered the CEO…
iXensor gears up to launch the PixoTest® COVID-19 Antigen Test and PixoHealth Pass
PixoTest® is among the fastest COVID-19 antigen tests for smarter pandemic management, detecting positive SARS-CoV-2 infection cases in as short as five minutes. The PixoTest® POCT Analyzer offers prompt, accurate, and objective results through the standardized analysis of the rapid tests. PixoHealth Pass App is positioned as the digital screening tool…
PixoTest POCT System covered in The Sun Daily
iXensor was honored to present the innovative mobile health solution – PixoTest®POCT system at Taiwan Excellence (Taiwan External Trade Development Council)’s virtual conference titled “Aging Wisely with Trusty Healthcare” on September 16th. “the Sun daily” from Malaysia reported as follow: “iXensor developed its PixoTest®POCT System which is the world’s first mobile device…
Eveline featured in Pregnant and Perfect
Our Eveline Digital Ovulation Test got featured in Pregnant and Perfect, a virtual community that focusses on the universal and diverse experiences of all the mothers and moms-to-be out there. Have a read here: https://pregnantandperfect.com/how-to-get-pregnant-fast/
iXensor tackles COVID-19 with two testing solutions in the pipeline
TAIPEI, TAIWAN – May 18th, 2020 – iXensor Co., Ltd. (6734.TWO). On February 21st, 2020, iXensor formed the COMBAT project team to tackle the global COVID-19 pandemic challenge from the testing and digital solution perspective, aiming to aid the early detection of COVID-19 infections. Two state-of-the-art antigen-based testing solutions are…
Eveline Ovulation Kit wins 2020 NAPPA Award
Eveline’s unique smart features convinced the expert jury TAIPEI, TAIWAN – April 8, 2020 – Eveline, the world’s first AI-powered ovulation prediction kit, was selected as a winner of the 2020 National Parenting Product Awards (NAPPA). NAPPA is one of the longest-running awards programs in its industry in the USA….